The relationship between interleukin-6, tumor necrosis factor-α, and fatigue in terminally ill cancer patients

Palliative Medicine

Volumn 26, Issue 3, 2012, Pages 275-282

  Kwak, Sang Mi ^a   Choi, Youn Seon ^a   Yoon, Ho Min ^a   Kim, Dae Gyun ^a   Song, Seung Hun ^a   Lee, Young Jae ^b   Yeom, Chang Hwan ^c   Koh, Su Jin ^d   Park, Jeanno ^e   Lee, Myung Ah ^c   Suh, Sang Yeon ^f  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Good Samaritan Hospital   (South Korea)

^e Bobath Memorial Hospital   (South Korea)

^f Dongguk University   (South Korea)

Author keywords

Blood urea nitrogen; cytokine; fatigue; pain; physical performance; terminal cancer

Indexed keywords

ALBUMIN; BILIRUBIN; C REACTIVE PROTEIN; INTERLEUKIN 6; NITROGEN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER PATIENT; CROSS-SECTIONAL STUDY; DYSPNEA; FATIGUE; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PALLIATIVE THERAPY; PHYSICAL PERFORMANCE; QUESTIONNAIRE; SCORING SYSTEM; STRUCTURED INTERVIEW; TERMINALLY ILL PATIENT; UREA NITROGEN BLOOD LEVEL;

AGED; BLOOD UREA NITROGEN; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; INTERLEUKIN-6; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PALLIATIVE CARE; QUESTIONNAIRES; TERMINALLY ILL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863366905     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216311406991     Document Type: Article

References (48)

1. National Comprehensive Cancer Network. 'NCCN Practice Guidelines for Cancer-related Fatigue', http://www.nccn.org/professionals/physician-gls/PDF/ fatigue.pdf (2010, accessed 22 January 2010).
2. Andrykowski MA, Curran SL and Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 1998; 21: 1-18. (Pubitemid 28146209)
3. Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A and A'Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Canc 1999; 79: 1479-1486. (Pubitemid 29116808)
4. Morrow GR, Shelke AR, Roscoe JA, Hickok JT and Mustian K. Management of cancer-related fatigue. Cancer Invest 2005; 23: 229-239. (Pubitemid 40770741)
5. Herrinton LJ, Neslund-Dudas C, Rolnick SJ, Hornbrook MC, Bachman DJ, Darbinian JA, et al. Complications at the end of life in ovarian cancer. J Pain Symptom Manage 2007; 34: 237-243. (Pubitemid 47371073)
6. Tsai J-S, Wu C-H, Chiu T-Y, Hu W-Y and Chen C-Y. Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med 2006; 20: 617-622.
7. Stone P, Richards M, A'Hern R and Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000; 11: 561-567. (Pubitemid 30431378)
8. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K and Morrow GR. Mechanisms of cancer-related fatigue. Oncologist 2007; 12(Suppl 1): 22-34.
9. Hinds PS, Quargnenti A, Bush AJ, et al. An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer. Eur J Oncol Nurs 2000; 4: 6-17.
10. Crom DB, Hinds PS, Gattuso JS, Tyc V and Hudson MM. Creating the basis for a breast health program for female survivors of Hodgkin disease using a participatory research approach. Oncol Nurs Forum 2005; 32: 1131-1141.
11. Wang XS, Giralt SA, Mendoza TR, et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol 2002; 20: 1319-1328. (Pubitemid 34177439)
12. Okuyama T, Akechi T, Shima Y, et al. Factors correlated with fatigue in terminally ill cancer patients-a lon- gitudinal study. Proc Am Soc Clin Oncol 2001; 20: 299b(abstract 2949).
13. Hwang SS, Chang VT, Corpion C, Ohanian M and Kasimis B. A preliminary study of clinical predictors for lack of energy in patients with advanced cancer. Proc Am Soc Clin Oncol 1997; 16: 70a(abstract 241).
14. Portenoy RK and Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 1999; 4: 1-10. (Pubitemid 29102450)
15. Radbruch L, Strasser F, Elsner F, et al. Fatigue in palliative care patients - an EAPC approach. Palliat Med 2008; 22: 13-32. (Pubitemid 351351367)
16. Cella D, Kallich J, McDermott A and Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 2004; 15: 979-986. (Pubitemid 39004357)
17. Demetri GD, Kris M, Wade J, Degos L and Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998; 16: 3412-3425. (Pubitemid 28481641)
18. Meyers CA, Albitar M and Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005; 104: 788-793. (Pubitemid 41113679)
19. Greenberg DB, Gray JL, Mannix CM, Eisenthal S and Carey M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 1993; 8: 196-200. (Pubitemid 23148865)
20. Wilson CJ, Finch CE and Cohen HJ. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002; 50: 2041-2056. (Pubitemid 35462453)
21. Maier SF and Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998; 105: 83-107. (Pubitemid 128459559)
22. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92: 1684-1688. (Pubitemid 32939175)
23. Bower JE, Ganz PA, Aziz N and Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64: 604-611. (Pubitemid 34791163)
24. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW and Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006; 12: 2759-2766.
25. Rich T, Innominato PF, Boerner J, et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005; 11: 1757-1764. (Pubitemid 40471837)
26. Savard J, Simard S, Ivers H and Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J Clin Oncol 2005; 23: 6097-6106.
27. Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P and Fossa SD. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav Immun 2009; 23: 868-874.
28. Ahlberg K, Ekman T and Gaston-Johansson F. Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: a pilot study. Biol Res Nurs 2004; 5: 203-210.
29. Argiles JM, Busquets S and Lopez-Soriano FJ. The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol 2005; 37: 2036-2046. (Pubitemid 41213293)
30. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003; 48: 35-45. (Pubitemid 36091645)
31. Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005; 106: 2627-2632. (Pubitemid 41510733)
32. Omdal R and Gunnarsson R. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis-a pilot study. Rheumatol Int 2005; 25: 481-484. (Pubitemid 41186922)
33. Trikha M, Corringham R, Klein B and Rossi JF. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin Cancer Res 2003; 9: 4653-4665. (Pubitemid 37323267)
34. Tookman AJ, Jones CL, DeWitte M and Lodge PJ. Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab. Support Care Canc 2008; 16: 1131-1140.
35. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85: 1186-1196. (Pubitemid 29115600)
36. Okuyama T, Wang XS, Akechi T, et al. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage 2003; 25: 106-117. (Pubitemid 36183289)
37. Yun YH, Wang XS, Lee JS, et al. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage 2005; 29: 165-172. (Pubitemid 40279053)
38. Pepys MB and Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812. (Pubitemid 38057722)
39. Scott HR, McMillan DC, Brown DJ, Forrest LM, McArdle CS and Milroy R. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Canc 2003; 40: 295-299. (Pubitemid 36627709)
40. Booker R, Olson K, Pilarski LM, Noon JP and Bahlis NJ. The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma. Oncol Nurs Forum 2009; 36: 209-216.
41. Illman J, Corringham R, Robinson Jr D, et al. Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol 2005; 3: 37-50. (Pubitemid 41029582)
42. Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ and Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003; 21: 1660-1668. (Pubitemid 46638575)
43. Okuyama T, Tanaka K, Akechi T, et al. Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Symptom Manage 2001; 22: 554-564. (Pubitemid 32547444)
44. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S and Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997; 15: 1218-1234. (Pubitemid 27106310)
45. Stone PC, Abdul-Wahab A, Gibson JS, Wright RJ and Andrews PL. Fatigue in cancer patients is not related to changes in oxyhaemoglobin dissociation. Support Care Canc 2005; 13: 854-858. (Pubitemid 41414028)
46. Harrison AP, Nielsen AH, Eidemak I, Molsted S and Bartels EM. The uremic environment and muscle dysfunction in man and rat. Nephron Physiol 2006; 103: 33-42.
47. Wu BU, Johannes RS, Sun X, Conwell DL and Banks PA. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology 2009; 137: 129-135.
48. Inagaki M, Isono M, Okuyama T, et al. Plasma interleukin-6 and fatigue in terminally ill cancer patients. J Pain Symptom Manag 2008; 35: 153-161.